How Much Does Tirzepatide Cost Without Insurance? (2026 Guide)

Your Self-Pay Options

Prices below are as of 2026 and change frequently — verify current pricing on the manufacturer and program websites before making any decision.

1. Brand-name at list price

Zepbound and Mounjaro list prices have generally run around $1,000–$1,100 per month for the medication alone, with provider visits billed separately.

2. Manufacturer direct self-pay program (LillyDirect)

Eli Lilly sells Zepbound directly to self-pay patients through LillyDirect. Single-dose vials run roughly $299 per month at the starter dose up to about $499 per month at higher doses when refilled on schedule. You need a prescription from your own doctor or a telehealth provider, and provider visits are separate. This is the FDA-approved product with full FDA oversight of manufacturing and labeling.

3. Insurance copay programs

If your plan covers Zepbound, the manufacturer's savings card may reduce your copay substantially. Eligibility rules and caps apply, and government-insured patients are typically excluded. Check your plan's formulary and the manufacturer's current terms.

4. Compounded tirzepatide programs via telehealth

Some telehealth platforms offer compounded tirzepatide prepared by licensed US compounding pharmacies pursuant to a provider's prescription. Each platform sets its own pricing. FitFlowRx publishes flat pricing of $134 per month on its tirzepatide treatment page — provider consultation, medication if prescribed, and shipping included, and the same price at every dose. Medication is prescribed only if a licensed provider determines it is appropriate for you.

Compounded Is Not a Lower-Cost Substitute

Compounded tirzepatide is not FDA-approved: the final product does not undergo FDA review for safety, effectiveness, or manufacturing quality. It is prepared by a licensed US compounding pharmacy for an individual patient pursuant to a licensed provider's prescription. It is not a generic version of Zepbound or Mounjaro, and it is not a substitute for them.

Whether a compounded medication is appropriate for you is a clinical decision a licensed provider makes based on your health history — not a cost decision. If an FDA-approved product is available and appropriate for you, your provider may recommend it.

Semaglutide or Tirzepatide? A Clinical Decision

Tirzepatide and semaglutide are different medications with different mechanisms, and the right one for you depends on your health history, goals, and how you tolerate treatment — a decision to make with your provider, not on price alone. See our semaglutide cost guide and full comparison.

Price Is Only Half the Question

• Is a licensed provider actually reviewing your health history? (At FitFlow: providers of the Wasef Health medical group.)
• Is the pharmacy a licensed US pharmacy?
• Is pricing published before checkout, with no hidden fees?
• Does the program state plainly whether the medication is FDA-approved or compounded?
• Is the platform certified (FitFlow is LegitScript-certified)?

A low price from an unlicensed source is a warning sign, not a bargain.

This article is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any weight loss medication. Brand-name prices are drawn from public manufacturer pricing as of 2026 and change frequently. FitFlow is a telehealth platform and does not manufacture or compound medications. Compounded medications are prepared and dispensed by licensed U.S. compounding pharmacies pursuant to a prescription from a licensed provider; compounded drugs are not FDA-approved and are not a generic version of or substitute for any FDA-approved drug. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. FitFlowRx is not affiliated with Eli Lilly.